Cargando…
Cabozantinib-Induced Severe Cardiac Dysfunction: A Case Report and a Systematic Review of the Literature
Cabozantinib is a novel multitargeted receptor tyrosine kinase inhibitor commonly used to treat advanced renal cell carcinoma. Cardiotoxicity is not a previously well-described adverse effect of cabozantinib. We present a rare case of a 74-year-old male with a history of renal cell carcinoma who und...
Autores principales: | Buttar, Chandan, Lakhdar, Sofia, Nassar, Mahmoud, Landry, Ian, Munira, Most |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9057634/ https://www.ncbi.nlm.nih.gov/pubmed/35509750 http://dx.doi.org/10.7759/cureus.23740 |
Ejemplares similares
-
Outcomes With Left Ventricular Assist Device in End-Stage Renal Disease: A Systematic Review
por: Lakhdar, Sofia, et al.
Publicado: (2022) -
Comparative Assessment of the Long-Term Efficacy of Home-Based Versus Center-Based Cardiac Rehabilitation
por: Nso, Nso, et al.
Publicado: (2022) -
Factors Impacting Stent Thrombosis in Patients With Percutaneous Coronary Intervention and Coronary Stenting: A Systematic Review and Meta-Analysis
por: Nso, Nso, et al.
Publicado: (2022) -
Coronavirus Disease 2019 (COVID-19)-Induced Takotsubo Cardiomyopathy Prognosis in Geriatric Setting
por: Alshamam, Mohsen S, et al.
Publicado: (2021) -
Invasive Management of Vertebrobasilar Artery Stenosis and Occlusion: A Meta-Analysis on Efficacy and Safety Endpoints
por: Nso, Nso, et al.
Publicado: (2022)